BIO Protocol announced via a post on X that Long COVID Labs launches tomorrow, January 9, and it will accelerate a cure with DeSci.
The ticker of the project will be COVID and contributors include current and ex-Stanford researchers. The project will distribute 1% of the token supply to BIO holders who take part in the auction.
The project revealed via X important details about their vision, starting by saying that even if COVID-19 left the headlines, it never left peoples’ bodies. They addressed that 20% of recovered patients still have viral remnants including spike proteins in their bloodstream.
Also, they noted that 40% of people diagnosed with long Covid suffer from chronic illness.
Long COVID Labs was reportedly created to tackle these challenges with a bold vision:
The founders of the project include the following specialists:
In the X thread, the project claims to be the largest decentralized trial network ever built, involving machine learning that:
The project also noted that while Big Pharma ruled medicine for decades, profiting from slow and expensive processes that prioritize investors over patients, now Long COVID Labs will change this paradigm, focusing on patients.
The project uses a DAO model where individuals/patients hold governance tokens (COVID) that allow them to vote on proposals, recommend research directions, and oversee financial proceeds.
There are two ways to earn COVID tokens:
The BIO Protocol was announced as Binance Launchpool’s 63rd project in December 2024.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。